S2Medical AB (ST:S2M) — Market Cap & Net Worth
Market Cap & Net Worth: S2Medical AB (S2M)
S2Medical AB (ST:S2M) has a market capitalization of $522.23K (Skr4.85 Million) as of June 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #30832 globally and #730 in its home market, demonstrating a 3.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying S2Medical AB's stock price Skr0.01 by its total outstanding shares 898657054 (898.66 Million). Review S2Medical AB debt and liabilities to assess the company's total debt and financial obligations.
S2Medical AB Market Cap History: 2018 to 2026
S2Medical AB's market capitalization history from 2018 to 2026. Data shows change from $718.30 Million to $522.23K (-59.09% CAGR).
Index Memberships
S2Medical AB is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
First North Sweden PI
FNSESEKPI
|
$15.96 Billion | 0.00% | #250 of 281 |
Weight: S2Medical AB's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
S2Medical AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how S2Medical AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.07x
S2Medical AB's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $718.30 Million | $1.50 Million | -$10.73 Million | 480.28x | N/A |
| 2019 | $223.26 Million | $3.10 Million | -$18.44 Million | 72.06x | N/A |
| 2020 | $197.03 Million | $25.62 Million | -$15.08 Million | 7.69x | N/A |
| 2021 | $129.30 Million | $7.70 Million | -$20.08 Million | 16.79x | N/A |
| 2022 | $22.69 Million | $4.67 Million | -$29.46 Million | 4.86x | N/A |
| 2023 | $5.80 Million | $6.97 Million | -$22.71 Million | 0.83x | N/A |
| 2024 | $1.02 Million | $14.91 Million | $5.77 Million | 0.07x | 0.18x |
| 2025 | $1.03 Million | $14.36 Million | -$10.09 Million | 0.07x | N/A |
Competitor Companies of S2M by Market Capitalization
Companies near S2Medical AB in the global market cap rankings as of June 18, 2026.
Key companies related to S2Medical AB by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #164 globally with a market cap of $142.44 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #267 globally with a market cap of $94.60 Billion USD ( €80.92 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #340 globally with a market cap of $78.07 Billion USD ( €66.78 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #542 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | Intuitive Surgical Inc | NASDAQ:ISRG | $142.44 Billion | $402.18 |
| #267 | EssilorLuxottica S. A. | PA:EL | $94.60 Billion | €174.75 |
| #340 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $78.07 Billion | €91.50 |
| #542 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
S2Medical AB Historical Marketcap From 2018 to 2026
Between 2018 and today, S2Medical AB's market cap moved from $718.30 Million to $ 522.23K, with a yearly change of -59.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Skr522.23K | -49.53% |
| 2025 | Skr1.03 Million | +1.90% |
| 2024 | Skr1.02 Million | -82.50% |
| 2023 | Skr5.80 Million | -74.42% |
| 2022 | Skr22.69 Million | -82.45% |
| 2021 | Skr129.30 Million | -34.37% |
| 2020 | Skr197.03 Million | -11.75% |
| 2019 | Skr223.26 Million | -68.92% |
| 2018 | Skr718.30 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of S2Medical AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $522.23K USD |
| MoneyControl | $522.23K USD |
| MarketWatch | $522.23K USD |
| marketcap.company | $522.23K USD |
| Reuters | $522.23K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About S2Medical AB
S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and… Read more